孟鲁司特（Montelukast）是一种常用于治疗哮喘和过敏性鼻炎的白三烯受体拮抗剂。近年来，关于其安全性的讨论增多，尤其是美国食品药品监督管理局（FDA）在2020年发布黑框警告，指出该药可能引发严重的精神健康副作用，如焦虑、抑郁、失眠，甚至自杀念头。因此，不少患者和家长开始担忧：孟鲁司特还能吃吗？答案是：在医生指导下，仍可使用，但需谨慎评估风险与获益。对于轻度哮喘或季节性过敏患者，若其他治疗方案有效，可考虑替代药物；而对于中重度哮喘患者，若孟鲁司特能显著控制症状且无不良反应，继续使用可能是合理选择。重要的是，用药期间应密切观察情绪或行为变化，一旦出现异常，应立即停药并就医。总之，孟鲁司特并非禁药，但不再作为一线首选，尤其不推荐用于仅表现为轻微过敏症状的儿童。患者切勿自行用药或突然停药，务必遵医嘱，权衡利弊后科学使用。
Montelukast is a leukotriene receptor antagonist commonly prescribed for asthma and allergic rhinitis. In recent years, concerns about its safety have increased, particularly after the U.S. Food and Drug Administration (FDA) issued a boxed warning in 2020 highlighting serious mental health side effects, including anxiety, depression, insomnia, and even suicidal thoughts. This has led many patients and parents to wonder: Is montelukast still safe to take?The answer is yes—but with caution and under medical supervision. The decision to use montelukast should involve a careful assessment of risks versus benefits. For patients with mild asthma or seasonal allergies, alternative treatments may be preferable if they are effective. However, for those with moderate-to-severe asthma who respond well to montelukast without adverse effects, continuing the medication may remain a reasonable option. Crucially, patients should be closely monitored for any mood or behavioral changes during treatment, and discontinue use immediately if such symptoms arise.In summary, montelukast is not banned, but it is no longer recommended as a first-line therapy—especially for children with only mild allergic symptoms. Patients should never self-medicate or abruptly stop taking the drug without consulting a healthcare provider. Always follow professional medical advice to ensure safe and appropriate use.
原创文章，作者：admin，如若转载，请注明出处：https://ktez.cn/5407.html